Microbiome‐Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics
Immunity, Inflammation and Disease · 2026-10 · 14 (10)
DOI: 10.1002/iid3.70574 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 29.10.2026. Verfasst von Pranvi Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Gargi College, Delhi University, Delhi, India. Hauptthemen laut MEDLINE: Probiotics, Dermatitis, Atopic, Psoriasis, Gastrointestinal Microbiome. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The gut–skin axis links intestinal microbial activity with inflammatory skin disease, yet findings across atopic dermatitis, acne vulgaris, and psoriasis remain inconsistent. This review examines how disease biology and host context shape microbiome‐related effects and responses to probiotics. Materials and Methods Published clinical and experimental evidence on gut microbiota, immune and metabolic signaling, barrier dysfunction, inter‐organ communication, and probiotic interventions was narratively reviewed across atopic dermatitis, acne vulgaris, and psoriasis.
Results
Microbiome‐related mechanisms differ by disease. In atopic dermatitis, they intersect with barrier dysfunction and altered immune regulation. In acne vulgaris, metabolic, hormonal, dietary, and neuroendocrine factors modify their effects. In psoriasis, gut dysbiosis occurs within a broader setting of systemic immune activation. Probiotic outcomes are similarly variable and depend on strain, host characteristics, disease context, and study design.
Discussion
Gut–skin communication is better interpreted as part of an interconnected physiological network rather than a uniform linear pathway. Disease‐specific evaluation of microbiome changes and probiotic interventions may help explain conflicting findings and guide more targeted future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Gargi College, Delhi University, Delhi, India.
- Sally Mugabe Central Hospital, Harare, Zimbabwe.
- Department of Emergency Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Zoology, Deshbandhu College, University of Delhi, Delhi, India.
- Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
ORCID-Profile: Pranvi Sharma, Jaswinder Singh, Kiran Bala, Kajal Kamra
Zitieren
APA
Sharma, P., Nhokwara, T., Singh, J., Bala, K., & Kamra, K. (2026). Microbiome‐Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics. Immunity, Inflammation and Disease, 14(10). https://doi.org/10.1002/iid3.70574
Vancouver
Sharma P, Nhokwara T, Singh J, Bala K, Kamra K. Microbiome‐Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics. Immunity, Inflammation and Disease. 2026;14(10). doi:10.1002/iid3.70574
BibTeX
@article{Sharma2026,
author = {Sharma, Pranvi and Nhokwara, Tanaka and Singh, Jaswinder and Bala, Kiran and Kamra, Kajal},
title = {Microbiome‐Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {10},
doi = {10.1002/iid3.70574}
}
EUVIMED